Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.532
-0.102 (-16.06%)
Nov 21, 2024, 4:00 PM EST - Market closed
Eterna Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 27 | 10 | 17 | 217 | - | - | |
| Market Cap Growth | -51.83% | -41.17% | -92.39% | - | - | - | |
| Enterprise Value | 65 | 45 | 6 | 196 | - | - | |
| Last Close Price | 0.61 | 1.79 | 3.22 | 83.40 | - | - | |
| PS Ratio | 5.56 | 142.82 | - | - | - | - | |
| PB Ratio | -0.13 | 4.35 | 1.36 | 8.51 | - | - | |
| P/TBV Ratio | - | 51.66 | 1.64 | 9.25 | - | - | |
| EV/Sales Ratio | 108.72 | 658.24 | - | - | - | - | |
| Debt / Equity Ratio | -0.83 | 18.74 | 0.10 | 0.11 | 0.38 | 0.05 | |
| Asset Turnover | 0.02 | 0.00 | - | - | - | - | |
| Quick Ratio | 0.45 | 1.22 | 1.62 | 4.81 | 0.52 | 1.16 | |
| Current Ratio | 0.48 | 1.46 | 1.79 | 5.10 | 0.55 | 1.18 | |
| Return on Equity (ROE) | - | -302.20% | -130.70% | -739.07% | -83.79% | -88.87% | |
| Return on Assets (ROA) | -42.35% | -36.19% | -63.26% | -77.17% | -32.34% | -34.96% | |
| Return on Capital (ROIC) | -71.61% | -45.05% | -81.98% | -88.41% | -43.53% | -52.75% | |
| Earnings Yield | -142.33% | -223.12% | -148.88% | -56.47% | - | - | |
| FCF Yield | -54.91% | -210.34% | -128.86% | -10.89% | - | - | |
| Buyback Yield / Dilution | -11.09% | -74.17% | -40.92% | -146.19% | - | - | |
| Total Shareholder Return | -11.09% | -74.17% | -40.92% | -146.19% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.